Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Registry of Anti-epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS).

NCT01991041 is registered in ClinicalTrials.gov with Eisai Limited as lead sponsor.

NCT NCT01991041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01991041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Registry of Anti-epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS).
Lead sponsor
Eisai Limited
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
November 30, 2015
Enrollment
109 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

lennox-gastaut syndrome